447 related articles for article (PubMed ID: 28467623)
1. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
Gerlach LB; Olfson M; Kales HC; Maust DT
J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
[TBL] [Abstract][Full Text] [Related]
2. Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.
Rhee TG
J Gerontol A Biol Sci Med Sci; 2019 Nov; 74(12):1910-1915. PubMed ID: 30561526
[TBL] [Abstract][Full Text] [Related]
3. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
4. Patterns in Outpatient Benzodiazepine Prescribing in the United States.
Agarwal SD; Landon BE
JAMA Netw Open; 2019 Jan; 2(1):e187399. PubMed ID: 30681713
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
[TBL] [Abstract][Full Text] [Related]
6. Use of opioids and other analgesics by older adults in the United States, 1999-2010.
Steinman MA; Komaiko KD; Fung KZ; Ritchie CS
Pain Med; 2015 Feb; 16(2):319-27. PubMed ID: 25352175
[TBL] [Abstract][Full Text] [Related]
7. Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015.
Xu KY; Hartz SM; Borodovsky JT; Bierut LJ; Grucza RA
JAMA Netw Open; 2020 Dec; 3(12):e2028557. PubMed ID: 33295972
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.
Hwang CS; Kang EM; Kornegay CJ; Staffa JA; Jones CM; McAninch JK
Am J Prev Med; 2016 Aug; 51(2):151-160. PubMed ID: 27079639
[TBL] [Abstract][Full Text] [Related]
9. Physician Prescribing of Opioids to Patients at Increased Risk of Overdose From Benzodiazepine Use in the United States.
Ladapo JA; Larochelle MR; Chen A; Villalon MM; Vassar S; Huang DYC; Mafi JN
JAMA Psychiatry; 2018 Jun; 75(6):623-630. PubMed ID: 29710086
[TBL] [Abstract][Full Text] [Related]
10. Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.
Parent S; Nolan S; Fairbairn N; Ye M; Wu A; Montaner J; Barrios R; Ti L;
Int J Drug Policy; 2019 May; 67():52-57. PubMed ID: 30897373
[TBL] [Abstract][Full Text] [Related]
11. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
12. Predictors of CNS-Active Medication Use and Polypharmacy Among Homebound Older Adults With Depression.
Choi NG; Marti CN; Kunik ME
Psychiatr Serv; 2020 Aug; 71(8):847-850. PubMed ID: 32340595
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults.
Musich S; Wang SS; Slindee LB; Ruiz J; Yeh CS
Popul Health Manag; 2020 Aug; 23(4):286-296. PubMed ID: 31765280
[TBL] [Abstract][Full Text] [Related]
14. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
15. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.
Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):885-92. PubMed ID: 25906971
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).
Slater N; White S; Frisher M
BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy and Potentially Inappropriate Medication Use in Older Adults With Systemic Lupus Erythematosus.
Séguin DJ; Peschken CA; Dolovich C; Grymonpre RE; St John PD; Tisseverasinghe A
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):356-364. PubMed ID: 34369087
[TBL] [Abstract][Full Text] [Related]
18. High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.
Silva Almodóvar A; Nahata MC
J Am Geriatr Soc; 2023 Jan; 71(1):98-108. PubMed ID: 36289563
[TBL] [Abstract][Full Text] [Related]
19. Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.
Rose AJ; Bernson D; Chui KKH; Land T; Walley AY; LaRochelle MR; Stein BD; Stopka TJ
J Gen Intern Med; 2018 Sep; 33(9):1512-1519. PubMed ID: 29948815
[TBL] [Abstract][Full Text] [Related]
20. Prescriptions for opioids and opioid-included polypharmacy: An analysis of the National Hospital Ambulatory Medical Care Survey.
Rivera JC
J Opioid Manag; 2020 Sep/Oct 2020; 16(5):329-339. PubMed ID: 33226090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
